Skip to main content

Portside Wealth Group, LLC

Position in NVS — Novartis AG

CIK 1978608 Provo, UT

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$1,944,738
+$332,921 QoQ
Shares Held
12,409
+17.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#440
of 1,603 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Portside Wealth Group, LLC holds $35,072,554 across 13 Drug Manufacturers - General names. NVS ranks #8 (5.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
12,409 $1,944,738

All Filings in NVS

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,944,738 12,409
2026-03-31 $1,611,817 10,552
2025-12-31 $1,048,639 7,606
2025-09-30 $786,111 6,130
2025-06-30 $627,436 5,185
2025-03-31 $515,260 4,622
2024-12-31 $497,935 5,117
2024-09-30 $503,211 4,375
2024-06-30 $319,380 3,000
2024-03-31 $280,613 2,901
2023-12-31 $276,152 2,735
2023-09-30 $244,973 2,405